Literature DB >> 23515755

Lichtenstein repair of indirect inguinal hernias with acellular tissue matrix grafts in adolescent patients: a prospective, randomized, controlled trial.

Ying-mo Shen1, Jie Chen, Mao-lin Tian, Shuo Yang, Su-jun Liu, Ming-gang Wang.   

Abstract

PURPOSE: To evaluate the outcomes of Lichtenstein hernioplasty using acellular tissue matrix (ACTM) grafts in adolescent patients.
METHODS: One hundred patients, 13-18 years old, with primary unilateral indirect inguinal hernias, were randomly assigned to receive Lichtenstein hernioplasty using ACTM or traditional high ligation of the hernia sac (control group).The outcome measures were the length of the operation, postoperative visual analogue scale (VAS) pain score, length of hospitalization, postoperative complications and recurrence rate.
RESULTS: The length of hospitalization and VAS score were not different between the groups, and the minimum follow-up was 30 months. No postoperative wound infections, chronic postoperative pain or local foreign body sensation occurred in either group. Six patients (14.3 %) in the experimental group and five (11.6 %) in the control group developed scrotal hydroceles (P > 0.05); all resolved with conservative management. There were no recurrences in the experimental group, while there were three (6 %) in the control group (P > 0.05) and all occurred in patients with Gilbert type 3 hernias.
CONCLUSIONS: Lichtenstein hernioplasty using ACTM grafts has comparable safety and efficacy to traditional high ligation of the indirect hernia sac in adolescent patients. ACTM can reduce the incidence of recurrence in adolescents with Gilbert type 3 hernias.

Entities:  

Mesh:

Year:  2013        PMID: 23515755     DOI: 10.1007/s00595-013-0550-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  40 in total

1.  RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering.

Authors:  Xiaochao Dong; Xufeng Wei; Wei Yi; Chunhu Gu; Xiaojun Kang; Yang Liu; Qiang Li; Dinghua Yi
Journal:  J Mater Sci Mater Med       Date:  2009-06-09       Impact factor: 3.896

2.  Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction.

Authors:  Karem C Harth; Michael J Rosen
Journal:  Surg Innov       Date:  2009-12-22       Impact factor: 2.058

3.  The tension-free hernioplasty.

Authors:  I L Lichtenstein; A G Shulman; P K Amid; M M Montllor
Journal:  Am J Surg       Date:  1989-02       Impact factor: 2.565

4.  An anatomic and functional classification for the diagnosis and treatment of inguinal hernia.

Authors:  A I Gilbert
Journal:  Am J Surg       Date:  1989-03       Impact factor: 2.565

5.  The biomechanical behavior and host response to porcine-derived small intestine submucosa, pericardium and dermal matrix acellular grafts in a rat abdominal defect model.

Authors:  Jian Zhang; Guan Yu Wang; Yi Pin Xiao; Lie Ying Fan; Qiang Wang
Journal:  Biomaterials       Date:  2011-07-08       Impact factor: 12.479

6.  Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields.

Authors:  M E Franklin; J J Gonzalez; R P Michaelson; J L Glass; D A Chock
Journal:  Hernia       Date:  2002-10-19       Impact factor: 4.739

7.  Different bladder defects reconstructed with bladder acellular matrix grafts in a rabbit model.

Authors:  W-D Zhu; Y-M Xu; C Feng; Q Fu; L-J Song
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

8.  Laparoscopic exploration for the clinically undetected hernia in infancy and childhood.

Authors:  D P Geisler; S Jegathesan; M C Parmley; J M McGee; M G Nolen; T A Broughan
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

9.  Repair of abdominal wall defects with bovine pericardium.

Authors:  Jonathan N Limpert; Ankit R Desai; Arthur L Kumpf; Michael A Fallucco; Della L Aridge
Journal:  Am J Surg       Date:  2009-10-06       Impact factor: 2.565

10.  [Focusing of inguinal hernia in children].

Authors:  P Galinier; O Bouali; M Juricic; N Smail
Journal:  Arch Pediatr       Date:  2007-03-07       Impact factor: 1.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.